BGM
Qilian International Holding Group Ltd - Class A (BGM)
Healthcare • NASDAQ • $0.29+2.38%
- Symbol
- BGM
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Price
- $0.29
- Daily Change
- +2.38%
- Market Cap
- $58.78M
- Trailing P/E
- N/A
- Forward P/E
- N/A
- 52W High
- $17.17
- 52W Low
- $0.27
- Analyst Target
- N/A
- Dividend Yield
- N/A
- Beta
- N/A
BGM Group Ltd., through its subsidiaries, operates as a pharmaceutical and chemical company in China. It offers oxytetracycline products, including Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline active pharmaceutical ingredients, which are used by pharmaceutical companies in the manufacturing of medications that use oxytetracycline as an active ingredient. The company also provides licorice products, such as Gan Di Xin, a medicine made from raw licorice materials; Qilian Shan licorice extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, an ingredient for medical preparation companies to produce com…
Company websiteResearch BGM on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.